Table 2.

Mean and SEM (in parentheses) number of Fos/CTb-IR dual-labeled, percentages of c-Fos-IR cells expressing CTb-IR (% c-Fos), and percentages of CTb-IR cells expressing c-Fos-IR (% CTb) after CTb injection into LH or PeF

Count% c-Fos% CTb
LH–ABA (n = 4)LH–ABB (n = 3)PeF–ABA (n = 4)LH–ABA (n = 4)LH– ABB (n = 3)PeF–ABA (n = 4)LH–ABA (n = 4)LH– ABB (n = 3)PeF–ABA (n = 4)
AcbShDm6 (2.7)13.7a (0.8)0.5 (0.5)6.5 (3.1)16.6a (2.8)0.4 (0.4)3.0 (1.2)6.4a (0.3)0.5 (0.5)
AcbShV17.5b (4.4)3.7 (1.4)0.25 (0.3)17.3b (3.7)7.7 (3.3)0.3 (0.3)4.8b (0.8)1.7 (0.7)0.3 (0.3)
AcbC4.3 (2.4)2.7 (0.8)0 (0)6.4 (4.5)2.8 (1.0)0 (0)1.7 (0.9)2.7 (1.3)0 (0)
plPFc11 (5.3)7.7 (4)15.3 (5)4.4 (1.9)4.3 (1.8)6.8 (2.1)5 (2.2)5.2 (1.7)7.4 (2.6)
ilPFc9.5 (4.7)9.3 (3.1)12.5 (4.9)6.6 (2.7)8.3 (1.7)9 (1.5)6.4 (3.2)6.2 (1.2)7.7 (2.2)
PvTa15.5 (4)18.7 (3)31.3c (1.8)7.8 (2.4)9.8 (1.8)14.5c (0.4)18.2 (1.7)19.5 (0.7)27.3c (3)
PvTm8.5 (3)8 (2.8)8.7 (1.5)9.1 (3.2)7.6 (2.7)9.2 (1.1)19.3 (7.4)17.1 (4.8)21.7 (6.8)
PvTp8.8 (6.1)5.7 (0.3)11.3 (4.5)11.5 (9.1)5.3 (0.7)7.8 (2.8)11.8 (7.1)12.7 (1.0)20.7 (5.5)
VTA7 (4.1)13.3 (3.5)6.3 (1.5)15.6 (3.6)35.3a (3.7)11.1d (1.2)8.5 (3.7)18.1 (6.3)10 (2.5)
DR12.3 (6.5)8.3 (1.3)17.3 (8.1)12.6 (4.9)14.5 (1.3)14.8 (6.0)6.8 (3.6)4.7 (0.7)13.3 (5.8)
LC3.8 (1.9)3 (0.5)4 (2.4)20.0 (8.8)35.7 (19.3)15.3 (10.3)5.4 (2.5)3.6 (0.9)5.7 (3.4)
  • aLH-ABB > LH-ABA, p < 0.05;

  • bLH–ABA > LH–ABB, p < 0.05;

  • cPeF-ABA > LH-ABA/ABB, p < 0.05;

  • dPeF–ABA < LH-ABA/ABB, p < 0.05.

  • PVTa, Anterior PVT; PVTm, middle PVT; PVTp, posterior PVT; DR, dorsal raphe; LC, locus coeruleus.